Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis

Arquivos de Neuro-Psiquiatria

Volumn 60, Issue 3 B, 2002, Pages 721-724

  Lana Peixoto, Marco Aurélio ^a   Teixeira Jr , Antônio Lúcio ^a   Haase, Vitor Geraldi ^a  

^a NONE

Author keywords

Depression; Interferon beta 1a; Multiple sclerosis; Suicidal ideation

Indexed keywords

BETA1A INTERFERON; METHYLPREDNISOLONE;

ADULT; AFFECTIVE NEUROSIS; ANXIETY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; HUMAN; IRRITABILITY; MALE; MOOD; MULTIPLE SCLEROSIS; RELAPSE; SUICIDE; TREATMENT OUTCOME;

EID: 0036734712     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2002000500007     Document Type: Article

References (35)

1. Stenager E. Historical and psychiatric aspects of multiple sclerosis. Acta Psychiatr Scand 1990;84:398.
2. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol 1990;47:98-104.
3. Sadovnik AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology 1996;46:628-632.
4. Schiffer RB, Babigian HM. Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: an epidemiologic study. Arch Neurol 1984;41:1067-1069.
5. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987;9:426-434.
6. Zorzon M, Masi R, Nasuelli D, et al. Depression and anxiety in multiple sclerosis: a clinical and MR1 study in 95 subjects. J Neurol 2001;248:416-421.
7. Berg RM, Supprian T, Thomae J, et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler 2000;6:156-162.
8. Sabatini U, Pozzilli C, Pantano P, et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry 1996;39:970-975.
9. Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A. Lesions in the left arcuate fasciculus of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1997;49:1105-1110.
10. Feinstein A. Multiple sclerosis, disease modifying treatments and depression: a critical methodological review. Mult Scler 2000;6:343-348.
11. Feinstein A. The clinical neuropsychiatry of multiple sclerosis. Cambridge: University Press, 1999:26-50.
12. Sadovnick AD, Eisen K, Ebers GC, Patty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991;41:1193-1196.
13. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952.
14. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology 1996;46:552-554.
15. The INFbeta Multiple Sclerosis Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: 1. Clinical results of a multicenter, randomized, double-blind, placebo controlled trial. Neurology 1993;43:655-661.
16. Borras C, Rio J, Porcel J, et al. Emotional state of patients with relapsing-remitting MS treated with interferonbeta-1b. Neurology 1999;52:1636-1639.
17. European Study Group on Interferon beta-1b in Secondary Progressive MS. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet 1998;352:1491-1497.
18. Patten SB, Metz LM. Interferon beta-1a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from PRISMS clinical trial. Mult Scler 2001;7:243-248.
19. Mohr DC, Likosky W, Dwyer P, et al. Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis. Arch Neurol 1999;56:1263-1265.
20. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961-966.
21. Janssen HLA, Brouwser JT, van der Mast RC, Schalm SW. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1994;21:241-243.
22. Mohr DC, Goodkin DE, Likosky W, et al. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997;54:531-533.
23. Licinio J, Kling MA, Hauser P. Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes. Semin Oncol 1998;25(Suppl 1):30-38.
24. Foley FW, Traugott U, LaRocca NG, et al. A prospective study of depression and immune dysregulation in multiple sclerosis. Arch Neurol 1992;55:238-244.
25. Honer WG, Hurwitz T, Li DKB, Palmer M, Paty DW. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 1987;44:187-190.
26. Rao SM, Leo GJ, Haughton VM, et al. Workshop on neurobehavioral disorders in multiple sclerosis. Arch Neurol 1993;50:658-662.
27. Absher JR. Clinico-analysis of patients with multiple sclerosis and depression. Neurology 1990;49:305-381.
28. Reischies FM, Baum K, Brau H, et al. Cerebral magnetic resonance imaging findings in multiple sclerosis: relation to disturbance of affect, drive and cognition. Arch Neurol 1988;45:1114-1116.
29. Becker G, Truck U, Bogdahn U, Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res Neuroimaging 1994;55:75-84.
30. Becker T, Becker G, Seufert J, Hofmann E. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 1997;63:590-596.
31. Kahana E, Leibowitz U, Alter M. Cerebral multiple sclerosis. Neurology 1971;21:1179-1185.
32. Paykel ES, Myers JK, Lindethall JJ, Tanner J. Suicidal feelings in general population: a prevalence study. Br J Psychiatry 1974;124:460-469.
33. Stenager EN, Stenager E, Henrikson NK, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 1992;55:869-876.
34. Roos BE. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological disease. Eur Neurol 1974;11:37-45.
35. Sandyk R, Awebuch G. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. Int J Neurosci 1993;71:173-182.